NCT00892229View on ClinicalTrials.gov

Buccal Versus Vaginal Misoprostol in Surgical Termination of the First Trimester Missed Abortion in Erbil

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

January 31, 2008

Study Completion Date

March 31, 2008

Conditions
Missed Abortion
Interventions
DRUG

Misoprostol (given buccally)

400 microgram misoprostol given buccally three hours before dilation and curettage (PHARMACIA CORPORATION - Istanbul, serial number 022-00, a tablet contains 200 micrograms)

DRUG

Misoprostol (given vaginally)

400 microgram misoprostol (MISOPROSTOL - PHARMACIA CORPORATION - Istanbul, serial number 022-00, a tablet contains 200 micrograms)

Trial Locations (1)

00964

Iraqi Medical Specialization, Risafa

All Listed Sponsors
collaborator

NEGATIVE

AMBIG

lead

Hawler Medical University

OTHER

NCT00892229 - Buccal Versus Vaginal Misoprostol in Surgical Termination of the First Trimester Missed Abortion in Erbil | Biotech Hunter | Biotech Hunter